Dr Chernew asks panelists how patients might learn about clinical trials, and how trials handle treatment placebos.
Dr Chernew asks panelists how patients might learn about clinical trials, and how trials handle treatment placebos.
Ms Young says that some patients find out about trials through their doctor, but it is difficult to reach patients in the greater community. Websites like Myeloma.Trials.com can help patients find trials by disease type and location. There is also MMRF’s Community Gateway, which helps target patients through questions in a survey. She adds that few cancer trails consider the use of placebo drugs. She says phase 3 trials are “no-brainers” for patients.
Dr Kumar adds that clinical trials are important because they will be the future of myeloma treatment. Patients’ awareness of these trials is essential.
Artificial Intelligence May Help Differentiate Colon Carcinoma From Acute Diverticulitis
January 27th 2023Colon carcinoma and acute diverticulitis have similar computed tomography imaging features that can make differential diagnosis difficult for radiologists, but a novel artificial intelligence assistance model was shown to help diagnostic accuracy.
Read More
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
February 3rd 2022On this episode of Managed Care Cast, we speak with Meghan Gutierrez, CEO of the Lymphoma Research Foundation, about financial toxicity, how the pandemic has affected patients’ financial needs when they have cancer, health care disparities and care gaps, and more.
Listen
Interstitial Lung Abnormalities Impact OS in NSCLC Patients Receiving CRT, Adjuvant Durvalumab
January 19th 2023Pretreatment interstitial lung abnormalities were associated with worse overall and cause-specific survival in Japanese patients receiving chemoradiotherapy followed by adjuvant durvalumab for locally advanced non–small-cell lung cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512